Latest news with #Orthofix
Yahoo
6 days ago
- Business
- Yahoo
Barrington Lifts PT on Orthofix Medical (OFIX) to $17 From $16, Keeps an Overweight Rating
Orthofix Medical Inc. (NASDAQ:OFIX) is one of the . Barrington analyst Michael Petusky raised the firm's price target on Orthofix Medical Inc. (NASDAQ:OFIX) to $17 from $16 on August 6, keeping an Outperform rating on the shares. A surgeon using a bone growth stimulator device in a modern operating theatre. The analyst told investors in a research note that Orthofix Medical Inc. (NASDAQ:OFIX) reported strong fiscal Q2 results and affirmed its 2025 outlook, supporting the optimistic rating. Orthofix Medical Inc. (NASDAQ:OFIX) announced its fiscal Q2 2025 results on August 5, reporting net sales of $203.1 million for the quarter, representing a 2% growth on a reported basis and 4% on a pro forma constant currency basis compared to Q2 2024. U.S. Spine Fixation underwent a net sales growth of 5% and procedure volume growth of 7% compared to the same quarter last year, while Bone Growth Therapies' net sales reached $62.6 million, representing growth of 6%. Orthofix Medical Inc. (NASDAQ:OFIX) provides medical devices and operates through the Global Spine and Global Extremities business segments. Its Global Spine reporting segment encompasses three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. While we acknowledge the potential of OFIX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Business Wire
16-07-2025
- Business
- Business Wire
Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate at the Canaccord Genuity 45th Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 13, 2025 at 9:00 am Eastern Time. Interested parties can access the live and archived webcast of the presentation in the 'Events & Presentations' section of the Orthofix Investor Relations Website at Internet Posting of Information Orthofix routinely posts information that may be important to investors in the 'Investors' section of its website at Orthofix encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix. About Orthofix Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, Orthofix delivers exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system. To learn more, visit and follow on LinkedIn.
Globe and Mail
15-07-2025
- Business
- Globe and Mail
Orthofix to Report Second Quarter 2025 Financial Results
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID 4830464. A webcast of the conference call and a copy of the release may be accessed at Internet Posting of Information Orthofix routinely posts information that may be important to investors in the 'Investor Relations' section of its website at Orthofix encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix. About Orthofix Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system. To learn more, visit and follow on LinkedIn.
Business Wire
15-07-2025
- Business
- Business Wire
Orthofix to Report Second Quarter 2025 Financial Results
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID 4830464. A webcast of the conference call and a copy of the release may be accessed at Internet Posting of Information Orthofix routinely posts information that may be important to investors in the 'Investor Relations' section of its website at Orthofix encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix. About Orthofix Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system. To learn more, visit and follow on LinkedIn.
San Francisco Chronicle
06-05-2025
- Business
- San Francisco Chronicle
Orthofix: Q1 Earnings Snapshot
LEWISVILLE, Texas (AP) — LEWISVILLE, Texas (AP) — Orthofix Medical Inc. (OFIX) on Tuesday reported a loss of $53.1 million in its first quarter. On a per-share basis, the Lewisville, Texas-based company said it had a loss of $1.35. Losses, adjusted for non-recurring costs and stock option expense, were 8 cents per share. The medical device maker posted revenue of $193.6 million in the period. Orthofix expects full-year revenue in the range of $808 million to $816 million.
